Ownership history in BRAIDWELL LP · 2 quarters on record
This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 475,400 | -609,000 | -56.2% | 0.67% | $22.6M | — |
| 2024 Q2 | INITIATED | 1,084,400 | — | — | 0.80% | $25.4M | — |